Impact of COVID-19 on estimands considerations in Oncology

Autor:	Sailer, Martin Oliver, Degtyarev, Evgeny, Zhou, Jiangxiu, Casey, Michelle, Tang, Rui, Liu, Feng, Shentu, Yue, Yung, Godwin, Liu, Yi, Rufibach, Kaspar
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	ddc: 610 oncology estimand COVID-19 clinical trial EFSPI 610 Medical sciences Medicine
Zdroj:	65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS); 20200906-20200909; Berlin; DOCAbstr. 171 /20210226/
Popis:	An addendum to the guideline on statistical principles for clinical trials was issued in 2019 [ref:2] introducing the estimands framework. This framework aims to align trial objectives with study design and statistical analysis. An industry working group for estimands targeted specifically[for full text, please go to the a.m. URL] 65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87448574c1166181742683f4c265176 http://www.egms.de/en/meetings/gmds2020/20gmds087.shtml Zobrazit plný text záznamu